DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GDC-0917

Generic Name: GDC-0917

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₃₆N_₆O_₄S

CAS Number: 1446182-94-0

Unique Ingredient Identifier: KWH46ZDG32

Overview

CUDC-427 has been used in trials studying the treatment of LYMPHOMA and Solid Cancers.

Background

CUDC-427 has been used in trials studying the treatment of LYMPHOMA and Solid Cancers.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma

Phase 1

Terminated

Posted: 2013/07/25

Sponsor:Curis, Inc.

A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma

Phase 1

Completed

Posted: 2010/10/22

Sponsor:Genentech, Inc.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy